يعرض 1 - 20 نتائج من 155 نتيجة بحث عن '"Orrico-Sánchez, Alejandro"', وقت الاستعلام: 0.67s تنقيح النتائج
  1. 1
  2. 2
  3. 3
  4. 4
    Academic Journal
  5. 5
    Academic Journal

    Relation: Supplementary materials are available at The Journal of Infectious Diseases online (http://jid.oxfordjournals.org/). Supplementary materials consist of data provided by the author that are published to benefit the reader. The posted materials are not copyedited. The contents of all supplementary data are the sole responsibility of the authors. Questions or messages regarding errors should be addressed to the author.; http://hdl.handle.net/20.500.12466/4438

  6. 6
  7. 7
    Academic Journal
  8. 8
  9. 9
  10. 10
    Academic Journal
  11. 11
    Academic Journal
  12. 12
    Academic Journal
  13. 13
  14. 14
    Academic Journal
  15. 15
    Academic Journal

    المصدر: Orrico Sánchez, Alejandro, Martí Prats, Lucía, Cano Cebrián, María José, Polache Vengut, Ana Zornoza Sabina, Teodoro, Granero Maciá, Luis (2014). Disposition of d-penicillamine, a promising drug for preventing alcohol-relapse. Influence of dose, chronic alcohol consumption and age: studies in rat. Biopharmaceutics & Drug Disposition 35 5 284 295. https://doi.org/10.1002/bdd.1896

    مصطلحات موضوعية: tecnologia farmacèutica, farmacologia, farmàcia

    وصف الملف: application/pdf

    Relation: Biopharmaceutics & Drug Disposition, 2014, vol. 35, num. 5, p. 284-295; https://hdl.handle.net/10550/91252; 097160

  16. 16
    Academic Journal

    المصدر: Orrico Sánchez, Alejandro Martí Prats, Lucía Cano Cebrián, María José Granero Maciá, Luis Polache Vengut, Ana Zornoza Sabina, Teodoro 2017 Pre-Clinical Studies with D-Penicillamine as a Novel Pharmacological Strategy to Treat Alcoholism: Updated Evidences Frontiers In Behavioral Neuroscience 11 37. https://doi.org/10.3389/fnbeh.2017.00037

    مصطلحات موضوعية: alcohol, drogues

    وصف الملف: application/pdf

    Relation: Frontiers In Behavioral Neuroscience, 2017, vol. 11, num. 37; https://hdl.handle.net/10550/91219; 118141

  17. 17
    Academic Journal

    المساهمون: Neuroscience Paris Seine (NPS), Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS)-Institut de Biologie Paris Seine (IBPS), Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS), Centre de Recherches sur la Cognition Animale - UMR5169 (CRCA), Université Toulouse III - Paul Sabatier (UT3), Université de Toulouse (UT)-Université de Toulouse (UT)-Centre National de la Recherche Scientifique (CNRS)-Centre de Biologie Intégrative (CBI), Université de Toulouse (UT)-Université de Toulouse (UT)-Centre National de la Recherche Scientifique (CNRS)-Centre National de la Recherche Scientifique (CNRS)-Toulouse Mind & Brain Institut (TMBI), Université Toulouse - Jean Jaurès (UT2J), Université de Toulouse (UT)-Université de Toulouse (UT)-Université Toulouse III - Paul Sabatier (UT3), Université de Toulouse (UT)-Université Toulouse - Jean Jaurès (UT2J), Université de Toulouse (UT)-Université Toulouse III - Paul Sabatier (UT3), Université de Toulouse (UT), Hôpital Lariboisière-Fernand-Widal APHP, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)

    المصدر: ISSN: 2158-3188.

    مصطلحات موضوعية: [SCCO.NEUR]Cognitive science/Neuroscience

    Relation: info:eu-repo/semantics/altIdentifier/pmid/37775532; inserm-04224977; https://inserm.hal.science/inserm-04224977; https://inserm.hal.science/inserm-04224977/document; https://inserm.hal.science/inserm-04224977/file/AO%202023%20HAL.pdf; PUBMED: 37775532; PUBMEDCENTRAL: PMC10542329

  18. 18
    Academic Journal

    Relation: Supplementary Materials: The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/vaccines11101590/s1, Laboratory methods. Supplement Cellular Immunity, methods. Supplemental Table S1: Comparison of the characteristics of COVID-19 episodes by immunization status: analysis of primed individuals (with prior COVID-19 infection, having received one, or two doses) versus those who received a third booster dose; Supplementary Table S2: Participant characteristics associated with immunization, comparing between those primed (with prior COVID-19 infection and having received one, or two doses) and those who received a third booster dose. Supplementary Figure S1: DAG analysis; http://hdl.handle.net/20.500.12466/3744; https://doi.org/10.3390/vaccines11101590

  19. 19
  20. 20